PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

73 hedge funds and large institutions have $52.8M invested in Invesco Biotechnology & Genome ETF in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-4
Holders Change %
-5.19%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
16
Reduced
18
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wells Fargo
Wells Fargo
California
$5.25M
2
Citadel Advisors
Citadel Advisors
Florida
$1.78M
3
NDSI
Newman Dignan & Sheerar Inc
Rhode Island
$789K
4
LPL Financial
LPL Financial
California
$1.9M
5
CAM
Cresset Asset Management
Illinois
$226K

Top Sellers

1
UBS Group
UBS Group
Switzerland
$1.73M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$730K
3
ACM
Anfield Capital Management
California
$1.73M
4
US Bancorp
US Bancorp
Minnesota
$961K
5
UCFA
United Capital Financial Advisors
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAG
76
Private Advisor Group
New Jersey
– -$122K -2,098 Closed
CAN
77
Cetera Advisor Networks
California
– -$116K -1,994 Closed
JPLA
78
Joseph P. Lucia & Associates
New York
– -$37K -638 Closed
FANJ
79
Financial Architects (New Jersey)
New Jersey
– -$29K -500 Closed
AP
80
Advisors Preferred
Maryland
– -$7K -125 Closed
SCA
81
Stonebridge Capital Advisors
Minnesota
– -$6K -100 Closed
HWA
82
HHM Wealth Advisors
Tennessee
– -$6K -100 Closed
AIC
83
Archer Investment Corporation
Indiana
– -$2.33K -40 Closed
1 2 3
4